+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Pulmonary embolism - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary embolism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ischemic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Left Ventricular Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Left Ventricular Dysfunction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Thromboembolic Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Thromboembolic Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Brain Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
Chronic Stable Angina - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Stable Angina - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Coronary Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Coronary Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Venous Thromboembolism - Pipeline Insight, 2024 - Product Thumbnail Image

Venous Thromboembolism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Hereditary Angioedema - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Resistant Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Resistant Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Portal Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Portal Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Raynaud's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Raynaud's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Intermittent Claudication - Pipeline Insight, 2024 - Product Thumbnail Image

Intermittent Claudication - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dilated Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Brain Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2024 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Advanced Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Heart failure - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Heart failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
Chronic Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Intracranial Arterial Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Intracranial Arterial Diseases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more